Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Cancer Research|September 17, 2008
Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancerKarin G Hermans, Hetty A van der Korput, Ronald van Marion, et al.Journal of the National Cancer Institute|January 16, 2010
Verification and unmasking of widely used human esophageal adenocarcinoma cell linesJurjen J Boonstra, Ronald van Marion, David G Beer, et al.Cancer Research|May 3, 2003
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumorsLeendert H J Looijenga, Hans Stoop, Hubert P J C de Leeuw, et al.Annals of Surgery|January 15, 2011
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancerMark van Heijl, Jikke M Omloo, Mark I van Berge Henegouwen, et al.Human Molecular Genetics|May 13, 2004
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumorsPamela L Paris, Armann Andaya, Jane Fridlyand, et al.Annals of Surgery|November 8, 2014
Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survivalA Koen Talsma, Joel Shapiro, Caspar W N Looman, et al.The Lancet. Oncology|August 10, 2015
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialJoel Shapiro, J Jan B van Lanschot, Maarten C C M Hulshof, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2017
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS TrialBo Jan Noordman, Mathilde G E Verdam, Sjoerd M Lagarde, et al.Pageof 8